| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |